These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3389373)
21. Do amines induce occupational asthma in workers manufacturing polyurethane foams? Candura F; Moscato G Br J Ind Med; 1984 Nov; 41(4):552-3. PubMed ID: 6093853 [No Abstract] [Full Text] [Related]
22. Should systemic sclerosis be recognised as an occupational disease in Switzerland? Schmid M; Grolimund Berset D; Krief P; Zyska Cherix A; Danuser B; Rinaldo M Swiss Med Wkly; 2020 Feb; 150():w20193. PubMed ID: 32083706 [TBL] [Abstract][Full Text] [Related]
23. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects. Shapiro LS; Prince RK; Buckingham RB; Rodnan GP J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687 [TBL] [Abstract][Full Text] [Related]
24. Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis. Jinnin M; Ihn H; Asano Y; Yamane K; Yazawa N; Tamaki K Ann Rheum Dis; 2003 Oct; 62(10):1019-20. PubMed ID: 12972489 [No Abstract] [Full Text] [Related]
25. Penicillamine therapy in systemic sclerosis. Jayson MI; Lovell C; Black CM; Wilson RS Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):82-8. PubMed ID: 122683 [TBL] [Abstract][Full Text] [Related]
26. [Treatment of scleroderma and dermatomyositis in childhood]. Ansell BM Clin Ter; 1978 Jan; 84(2):123-31. PubMed ID: 648095 [No Abstract] [Full Text] [Related]
27. Familial systemic sclerosis following exposure to organic solvents and the possible implication of genetic factors. Calvani N; Silvestris F; Dammacco F Ann Ital Med Int; 2001; 16(3):175-8. PubMed ID: 11692907 [TBL] [Abstract][Full Text] [Related]
28. Penicillamine for systemic sclerosis? Drug Ther Bull; 1974 Sep; 12(19):75-6. PubMed ID: 4469492 [No Abstract] [Full Text] [Related]
30. [Scleroderma and environment. I. Scleroderma and sclerodermiform states induced by silica and chemical agents or drugs]. de la Espriella J; Crickx B Ann Dermatol Venereol; 1991; 118(12):948-53. PubMed ID: 1724723 [No Abstract] [Full Text] [Related]
32. [Experience using d-penicillamine in systemic scleroderma]. Nemchinov EN; Krel' AA; Shekhter AB; Rashchupkina ZP Klin Med (Mosk); 1982 Jan; 60(1):77-82. PubMed ID: 7078046 [No Abstract] [Full Text] [Related]
33. [Penicillamine in the treatment of patients with systemic scleroderma]. Gandzha IM Vrach Delo; 1987 May; (5):66-7. PubMed ID: 3617690 [No Abstract] [Full Text] [Related]
35. Treatment of scleroderma heart by D-penicillamine. Muers M; Stokes W Br Heart J; 1976 Aug; 38(8):864-7. PubMed ID: 135572 [TBL] [Abstract][Full Text] [Related]
36. Systemic sclerosis in German uranium miners under special consideration of autoantibody subsets and HLA class II alleles. Baur X; Rihs HP; Altmeyer P; Degens P; Conrad K; Mehlhorn J; Weber K; Wiebe V Respiration; 1996; 63(6):368-75. PubMed ID: 8933656 [TBL] [Abstract][Full Text] [Related]
37. [Vinyl chloride disease (author's transl)]. Lange CE; Jühe S; Stein G; Veltman G Int Arch Arbeitsmed; 1974; 32(1):1-32. PubMed ID: 4813693 [No Abstract] [Full Text] [Related]
39. Serial changes in scleroderma and idiopathic interstitial lung disease. Colp CR; Riker J; Williams MH Arch Intern Med; 1973 Oct; 132(4):506-15. PubMed ID: 4742404 [No Abstract] [Full Text] [Related]
40. [Penicillamine in the treatment of scleroderma]. Kobíková M; Stáva Z Cesk Dermatol; 1973 Dec; 48(6):408-10. PubMed ID: 4771784 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]